NOTCH3 and ovarian serous adenocarcinoma: Patients with high grade serous ovarian adenocarcinomas showing high Notch3 expression have a significantly worse clinical outcome, including reduced overall survival and shortened progression-free survival than patients with low Notch3 expression [12].